ScreenerHero

GETI-B Getinge AB

STO · SE · Healthcare · Medical Devices · getinge.com
248.00SEK+0.65%Mkt Cap: 6.42B $P/E: 25.04

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, a…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc. - Common Stock
$32.21BUSDP/E 33.7
GEHC
GE HealthCare Technologies Inc. - Common Stock
$29.24BUSDP/E 14.8
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
TXG
10x Genomics, Inc. - Common Stock
$12.18BUSD
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
GKOS
Glaukos Corporation
$9.67BUSD

Key Statistics

Company
Market Cap6.42B USD
Enterprise Value7.29B USD
Revenue (TTM)3.27B USD
Gross Profit1.59B USD
Net Income (TTM)215.98M USD
Revenue/Share125.70 SEK
Last Price248.00 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11.8K
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINUS37427X1046
Valuation
P/E (Trailing)25.04
P/E (Forward)22.52
PEG1.33
EV/EBITDA12.94
EV/Revenue2.23
P/S1.96
P/B2.17
EPS (TTM)9.83
EPS (Forward)10.94
52W Range
175.9095% of range251.40
52W High251.40 SEK
52W Low175.90 SEK
Profitability
Gross Margin47.63%
Oper. Margin16.12%
EBITDA Margin17.21%
Profit Margin6.46%
ROE7.67%
ROA4.00%
Growth
Revenue Growth1.70%
Earnings Growth60.50%
Cash Flow & Leverage
Operating CF377.73M USD
CapEx (TTM)125.69M USD
FCF Margin8.31%
FCF Yield4.24%
Net Debt865.46M USD
Net Debt/EBITDA1.54
Balance Sheet
Debt/Equity0.37
Current Ratio1.31
Quick Ratio0.74
Book Value/Sh113.61 SEK
Cash/Share7.53 SEK
Dividends
Fwd Div Rate4.75 SEK
Trail. Div Rate4.75 SEK
Div. Yield1.93%
5Y Avg Yield1.74%
Payout Ratio48.32%
Ex-Div DateApr 22, 2026
Pay Date—
Splits
Last Split4:1
Split DateNov 27, 2003
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)251.70 SEK
Upside (mean)+1.5%
Target Range165.00 SEK – 300.00 SEK
165.00+1.5% to mean300.00
# Analysts10
Ownership
Shares Out.254.15M
Float178.53M
Insiders15.20%
Institutions61.61%
Technical
SMA 50241.33 (+2.8%)
SMA 200210.19 (+18.0%)
Beta0.83
S&P 52W Chg14.58%
Avg Vol (30d)431.67K
Avg Vol (10d)486.91K
Technical Indicators
RSI (14)64.3
MACD5.6828
MACD Signal6.4515
MACD Hist.-0.7688
BB Upper251.04 SEK
BB Middle242.91 SEK
BB Lower234.77 SEK
BB Width6.70%
ATR (14)4.308 SEK
Vol Ratio (20d)0.64x